Featured Companies

In Episode 19, Season 3 of the Amplifying Scientific Innovation Video Podcast, Dr. Sophia Ononye-Onyia, Founder and CEO of The Sophia Consulting Firm, interviewed Dr. Carmen Guerra, MD MSCE FACP, Associate Professor of Medicine, Vice Chair of Diversity and Inclusion in the Department of Medicine and Associate Director of Diversity at the Abramson Cancer Center (ACC) at the Perelman School of Medicine, University of Pennsylvania. Here, Dr. Guerra discusses her research focus on better understanding and eliminating barriers to accessing cancer screening tests and cancer treatment clinical trials inclusive of structural inequities that limit health equity for minorities and socioeconomically disadvantaged individuals. For full transcript, please visit: https://sophiaconsultingfirm.com/blogs-%2B-articles/f/amplifying-scientific-innovation-dr-carmen-guerra-prof-penn

In Episode 17, Season 3 of the Amplifying Scientific Innovation Video Podcast, Dr. Sophia Ononye-Onyia, Founder and CEO of The Sophia Consulting Firm, interviewed Dr. Russell Weiner, Head Bioanalysis, Biomarker Development and Diagnostics at the Bill & Melinda Gates Medical Research Institute. Here, Dr. Weiner shares anecdotes of his scientific leadership journey, industry outlook and his organization’s focus on accelerating the product development timeline for diseases that disproportionately affect the world’s poorest populations, starting with malaria, tuberculosis, and diarrheal diseases—diseases that combined cause five deaths every minute. For full transcript, please visit: https://sophiaconsultingfirm.com/blogs-and-articles/f/amplifying-scientific-innovation-dr-russ-weiner-head-gates-mri

Special discussion with the National Institutes of Health (NIH)’s National Center for Advancing Translational Sciences (NCATS) on 3D Bioprinting during the American Association for Cancer Research (AACR) Virtual Meeting Week 1. Moderated by Dr. Sophia Ononye-Onyia, Founder and CEO, The Sophia Consulting Firm.  Featuring Mr. Sam Michael, Chief Information Officer and Director, Automation and Compound Management at the National Center for Advancing Translational Sciences (NCATS) and Dr. Marc Ferrer, Director of NCATS’ intramural 3-D Tissue Bioprinting Laboratory. The NIH is the largest public funder of biomedical research in the world, investing about $37 billion annually in medical research, The AACR Annual Meeting highlights the latest discoveries from across the spectrum of innovative cancer science and medicine. For full transcript, please visit: https://sophiaconsultingfirm.com/blogs-and-articles/f/amplifying-scientific-innovation-nih-3d-bioprinting-aacr-2021

In Episode 13, Season 3 of the Amplifying Scientific Innovation Video Podcast, Dr. Sophia Ononye-Onyia, Founder and CEO of The Sophia Consulting Firm, interviewed Dr. Christy Sheehy, Co-Founder and CEO of C. Light Technologies. Here, Dr. Sheehy shares anecdotes of her leadership journey, industry outlook and her pioneering work in advancing C. Light’s revolutionary eye tracking technology for neurological health. For full transcript, please visit: https://sophiaconsultingfirm.com/blogs-and-articles/f/amplifying-scientific-innovation-dr-christy-sheehy-ceo-c-light

In Episode 15, Season 2 of the Amplifying Scientific Innovation Video Podcast, Dr. Sophia Ononye-Onyia, Founder and CEO of The Sophia Consulting Firm, interviewed Dr. Anjelica Gonzalez, a Yale Associate Professor of Biomedical Engineering and Co-Founder of Aero Therapeutics. Here, Dr. Gonzalez shares personal anecdotes of her leadership journey; outlook on the life science industry; and her company’s unique focus on helping physicians in low-resource settings treat neonatal respiratory issues with their sustainable and cost-effective medical devices.

In Episode 13, Season 2 of the Amplifying Scientific Innovation Video Podcast, Dr. Sophia Ononye-Onyia, Founder and CEO of The Sophia Consulting Firm, interviewed Dr. Doug Manion, CEO, Kleo Pharmaceuticals. Here, Dr. Manion shares personal anecdotes of his leadership journey; outlook on the life science industry; and his company’s unique focus on redefining antibody therapeutics via its synthetic chemistry platform.

In this special episode, Dr. Sophia Ononye-Onyia, the Host and Creator of The Amplifying Scientific #Innovation Podcast, shares her favorite quotes from Season 1. Nine episodes aired between June 17, 2020 and  August 17, 2020. The podcast featured global biotechnology CEOs and senior executives who shared their unique leadership story, corporate vision and industry outlook. Stay tuned for details on Season 2 of the podcast that premieres on September 29, 2020.

Here, Mr. Tal shares his definition of scientific innovation, personal anecdotes of his CEO journey and his company's unique approach to scientific innovation via its recombinant human collagen (rhCollagen) technology platform. 

Here, Dr. Deisher shares her definition of scientific innovation, personal anecdotes of her CEO journey and her company's unique approach to scientific innovation through AVM0703, a repurposed drug that could be the first choice for no-option cancer, autoimmunity and infectious diseases such as COVID-19.

Here, Ms. Vnook shares her definition of scientific innovation, personal anecdotes of her CEO journey and her company's unique approach to scientific innovation through its proprietary and patented CUSP platform for cancer research.

Here, Dr. Geraci shares his definition of scientific innovation, unique leadership journey and his company's unique approach to scientific innovation via the provision of Augmented and Quantum Intelligence of Pharmaceutical Companies.